ESTRO 36 Programme book and exhibition guide

> Comparing dosimetry and toxicity of 5-field IMRT versus VMAT for prostate and pelvic nodal irradiation P. Turner (UK), S. Jain, D. Mitchell, J. Harney, F. Houghton, J. McAleese, D. Stewart, A. Hounsell, D. Irvine, G. Corey, K. Tumelty, K. Thompson, J. O’Sullivan > Pelvic SABR with HDR boost in intermediate and high risk prostate cancer (spare): early results H.B. Musunuru, A. Deabreu, M. Davidson, A. Ravi, J. Hlou, L. Ho, P. Cheung, D. Vesprini, S. Liu, W. Chu, H. Chung, L. Zhang, A. Loblaw (Canada) > Salvage stereotactic body radiotherapy for lymph node oligorecurrent prostate cancer G. Fanetti (Italy), C. Fodor, D. Ciardo, L. Santoro, C.M. Francia, M. Muto, A. Surgo, D. Zerini, G. Marvaso, G. Timon, P. Romanelli, E. Rondi, S. Comi, F. Cattani, D.V. Matei, M. Ferro, G. Musi, F. Nolè, O. De Cobelli, P. Ost, R. Orecchia, B.A. Jereczek-Fossa > Is stereotactic body radiation therapy a viable option for elderly patients with prostate cancer? C. Franzese (Italy), G. D’agostino, L. Di Brina, L. Cozzi, T. Comito, D. Franceschini, F. De Rose, P. Navarria, E. Clerici, A. Ascolese, A. Tozzi, C. Iftode, S. Tomatis, M. Scorsetti > Long-term quality of life after high-dose-rate brachytherapy boost for prostate cancer W. Busser (The Netherlands), I. Korfage, S. Aluwini > Dosimetric effect of seed-based prostate localisation on pelvic lymph nodes in high-risk prostate cancer R. Valentine (UK), E. Miguel Chumacero > Oligorecurrent nodal prostate cancer: long-term results of an elective nodal irradiation approach S. Tran (Switzerland), S. Jorcano, T. Falco, G. Lamanna, R. Miralbell, T. Zilli > Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer D. Candini (Spain), F. López Campos, C. Vallejo Ocaña, M. Martín Martín, A. Hervás Morón

ELECTRONIC POSTERS

EP-1340

EP-1341

EP-1342

EP-1343

EP-1344

EP-1345

EP-1346

EP-1347

POSTERS AND ELECTRONIC POSTERS | Programme and Exhibition Guide

258